Surgical Site Infection Market by Product, by Phase, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013 - 2023

  • ID: 4600403
  • Report
  • Region: Global
  • 177 pages
  • P&S Market Research
1 of 4

FEATURED COMPANIES

  • 3M Company
  • Becton
  • Covalon Technologies Ltd.
  • Dickinson Company.
  • HARTMANN GROUP
  • Medtronic plc
  • MORE
Global surgical site infection market is forecasted to reach $5.9 billion by 2023.

The market growth can be attributed to the development of technologically advanced products and growing geriatric population. Furthermore, increasing number of surgical procedures and rising incidence of SSIs are boosting the market growth.

Insights on market segments

Antibiotic prophylaxis products generated the largest revenue in the surgical site infection market in 2017. In most cases, patients’ sensitivity to certain drugs creates the need for specific antibiotics, which, in turn, adds to the treatment cost. Owing to this factor, antibiotic prophylaxis products continue to be in high demand in the market. However, the fastest growth in the market during the forecast period is expected from the antiseptic and disinfectant product category, with a CAGR of 7.4%.

Among all phases, the demand for products for the intraoperative phase is expected to exhibit the fastest growth in the surgical site infection market, at a CAGR of 6.6%, during the forecast period. This can be attributed to the wide usage of SSI preventive products during the intraoperative phase, as the chances of contamination to open wounds are the highest during this phase. Also, due to this reason, healthcare facilities are increasingly complying with the World Health Organization (WHO) guidelines that suggest MEA sures to prevent infections.

Hospitals have been contributing the largest revenue to the surgical site infection market, owing to increase in the number of surgeries and a significant increase in the number of hospitals on a global level, which is further leading to the increased use of products that help prevent surgical site infections.

Market is projected to witness the fastest growth in Asia-Pacific (APAC)

During the forecast period, the surgical site infection market is expected to witness the fastest growth in APAC, at a CAGR of 7.7%. The APAC surgical site infection market is also expected to reach $1,492.8 million by 2023. The market growth in APAC is mainly driven by growing geriatric population, rising incidence of SSIs, increasing adoption of technologically advanced products, and improving healthcare infrastructure.

According to the UN publication World Population Ageing 2017, in Asia, the number of people aged 60 years or above is estimated to increase from 549 million in 2017 to nearly 1.3 billion in 2050. Also, there is a high adoption rate of technologically advanced products in Japan. Besides, the country is witnessing an increase in its geriatric population. These factors are expected to continue driving the growth of the surgical site infection market market in Japan.

According to Japan Nosocomial Infections Surveillance (JANIS), a national surveillance program organized by Japan’s Ministry of Health, Labour and Welfare (MHLW) in 2017, there were 117,209 cases of methicillin-resistant Staphylococcus aureus (MRSA) infection in 2012, which increased to 177,768 in 2016. Thus, increase in surgical site infections in Japan is boosting the demand for products that help fight these infections.

Key players are seeking partnerships to increase their market share

In order to increase their market share, key players of the surgical site infection industry are entering into partnerships. For instance, in January 2018, Mölnlycke Health Care AB entered into a partnership with Tissue Analytics, a developer of digital wound-imaging platforms. With this partnership, both the companies intend to jointly develop and commercialize innovative digital solutions (such as comprehensive clinical decision support tools) for wound care professionals.

Some of the other key players operating in the surgical site infection market are 3M Company, STERIS plc, Stryker Corporation, Medtronic plc, Prescient Surgical Inc., Covalon Technologies Ltd., Surgical Site Infection Prevention LLC, HARTMANN GROUP, B. Braun Melsungen AG, and Becton, Dickinson and Company.

Global Surgical Site Infection (Ssi) Market Segmentation

Market Segmentation by Product

Antibiotic Prophylaxis Products
Antiseptics and Disinfectants
Wound Care Dressings
Surgical Drapes
Surgical Staff Clothing
Patient-Warming Products
Wound Care Supplementary Products
Clippers
Wound Irrigation Products
Others

Market Segmentation by Phase

Intraoperative Phase
Surgical Drapes
Surgical Staff Clothing
Wound Care Dressings
Patient-Warming Products
Antiseptics and Disinfectants
Wound Care Supplementary Products
Others
Preoperative Phase
Antibiotic Prophylaxis Products
Antiseptics and Disinfectants
Clippers
Others
Postoperative Phase
Wound Care Dressings
Wound Care Supplementary Products
Wound Irrigation Products
Others

Market Segmentation by End User

Hospitals
Ambulatory Surgery Centers (ASCs)
Clinics
Others

Market Segmentation by Geography

North America Surgical Site Infection Market
By Product
By Phase
By End User
By Country - U.S. and Canada

Europe Surgical Site Infection Market
By Product
By Phase
By End User
By Country - Germany, U.K., France, Italy, Spain, and Rest of Europe

Asia-Pacific (APAC) Surgical Site Infection Market
By Product
By Phase
By End User
By Country - Japan, China, India, Australia, South Korea, and Rest of APAC

Rest of the World (RoW) Surgical Site Infection Market
By Product
By Phase
By End User
By Country - Brazil, Mexico, Saudi Arabia, South Africa, and Rest of RoW

SSI Incidence and Forecast by Country

U.S. SSI Incidence and Forecast
By Surgery Type

Canada SSI Incidence and Forecast
By Surgery Type

Germany SSI Incidence and Forecast
By Surgery Type

U.K. SSI Incidence and Forecast
By Surgery Type

France SSI Incidence and Forecast
By Surgery Type

Italy SSI Incidence and Forecast
By Surgery Type

Spain SSI Incidence and Forecast
By Surgery Type

Japan SSI Incidence and Forecast
By Surgery Type

China SSI Incidence and Forecast
By Surgery Type

India SSI Incidence and Forecast
By Surgery Type

Australia SSI Incidence and Forecast
By Surgery Type

South Korea SSI Incidence and Forecast
By Surgery Type

Brazil SSI Incidence and Forecast
By Surgery Type

Mexico SSI Incidence and Forecast
By Surgery Type

Saudi Arabia SSI Incidence and Forecast
By Surgery Type

South Africa SSI Incidence and Forecast
By Surgery Type
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Company
  • Becton
  • Covalon Technologies Ltd.
  • Dickinson Company.
  • HARTMANN GROUP
  • Medtronic plc
  • MORE
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation By Product
1.3.2 Market Segmentation By Phase
1.3.3 Market Segmentation By End User
1.3.4 Market Segmentation By Geography
1.3.5 Analysis Period
1.3.6 Market Data Reporting Unit
1.3.6.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown Of Primary Research Respondents
2.2.1.1 By Region
2.2.1.2 By Industry Participant
2.2.1.3 By Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions For The Study

Chapter 3. Executive Summary

Chapter 4. Introduction
4.1 Definition Of Market Segments
4.1.1 By Product
4.1.1.1 Antibiotic Prophylaxis Products
4.1.1.2 Antiseptics And Disinfectants
4.1.1.3 Clippers
4.1.1.4 Patient-Warming Products
4.1.1.5 Wound Care Dressings
4.1.1.6 Wound Care Supplementary Products
4.1.1.7 Surgical Drapes
4.1.1.8 Surgical Staff Clothing
4.1.1.9 Wound Irrigation Products
4.1.1.10 Others
4.1.2 By Phase
4.1.2.1 Preoperative Phase
4.1.2.2 Intraoperative Phase
4.1.2.3 Postoperative Phase
4.1.3 By End User
4.1.3.1 Hospitals
4.1.3.2 Clinics
4.1.3.3 Ambulatory Surgery Centers (Ascs)
4.1.3.4 Others
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Rising Incidence Of Ssis
4.2.1.2 Increasing Number Of Surgical Procedures
4.2.1.3 Development Of Technologically Advanced Products
4.2.1.4 Growing Geriatric Population
4.2.1.5 Impact Analysis Of Drivers On Market Forecast
4.2.2 Restraints
4.2.2.1 Low Preventive MEA sures For Nosocomial Infections In Developing Nations
4.2.2.2 Lack Of Awareness About Ssis
4.2.2.3 Impact Analysis Of Restraints On Market Forecast
4.2.3 Opportunities
4.2.3.1 Increasing Initiatives By Various Organizations
4.2.3.2 Collaborations To Prevent Ssis
4.3 Porter’S Five Forces Analysis
4.3.1 Bargaining Power Of Buyers
4.3.2 Bargaining Power Of Suppliers
4.3.3 Intensity Of Rivalry
4.3.4 Threat Of New Entrants
4.3.5 Threat Of Substitutes

Chapter 5. Ssi Incidence And Forecast
5.1 U.S. Ssi Incidence And Forecast By Surgery Type
5.2 Canada Ssi Incidence And Forecast By Surgery Type
5.3 Germany Ssi Incidence And Forecast By Surgery Type
5.4 U.K. Ssi Incidence And Forecast By Surgery Type
5.5 France Ssi Incidence And Forecast By Surgery Type
5.6 Italy Ssi Incidence And Forecast By Surgery Type
5.7 Spain Ssi Incidence And Forecast By Surgery Type
5.8 Japan Ssi Incidence And Forecast By Surgery Type
5.9 China Ssi Incidence And Forecast By Surgery Type
5.10 India Ssi Incidence And Forecast By Surgery Type
5.11 Australia Ssi Incidence And Forecast By Surgery Type
5.12 South Korea Ssi Incidence And Forecast By Surgery Type
5.13 Brazil Ssi Incidence And Forecast By Surgery Type
5.14 Mexico Ssi Incidence And Forecast By Surgery Type
5.15 Saudi Arabia Ssi Incidence And Forecast By Surgery Type
5.16 South Africa Ssi Incidence And Forecast By Surgery Type

Chapter 6. Global Market Size And Forecast
6.1 By Product
6.2 By Phase
6.2.1 Global Intraoperative Ssi Market, By Product
6.2.2 Global Preoperative Ssi Market, By Product
6.2.3 Global Postoperative Ssi Market, By Product
6.3 By End User
6.3.1 Number Of End Users Utilizing Ssi Preventive Products
6.4 By Region

Chapter 7. North America Market Size And Forecast
7.1 By Product
7.2 By Phase
7.2.1 North America Intraoperative Ssi Market, By Product
7.2.2 North America Preoperative Ssi Market, By Product
7.2.3 North America Postoperative Ssi Market, By Product
7.3 By End User
7.3.1 Number Of End Users Utilizing Ssi Preventive Products
7.4 By Country

Chapter 8. Europe Market Size And Forecast
8.1 By Product
8.2 By Phase
8.2.1 Europe Intraoperative Ssi Market, By Product
8.2.2 Europe Preoperative Ssi Market, By Product
8.2.3 Europe Postoperative Ssi Market, By Product
8.3 By End User
8.3.1 Number Of End Users Utilizing Ssi Preventive Products
8.4 By Country

Chapter 9. APAC Market Size And Forecast
9.1 By Product
9.2 By Phase
9.2.1 APAC Intraoperative Ssi Market, By Product
9.2.2 APAC Preoperative Ssi Market, By Product
9.2.3 APAC Postoperative Ssi Market, By Product
9.3 By End User
9.3.1 Number Of End Users Utilizing Ssi Preventive Products
9.4 By Country

Chapter 10. ROW Market Size And Forecast
10.1 By Product
10.2 By Phase
10.2.1 ROW Intraoperative Ssi Market, By Product
10.2.2 ROW Preoperative Ssi Market, By Product
10.2.3 ROW Postoperative Ssi Market, By Product
10.3 By End User
10.3.1 Number Of End Users Utilizing Ssi Preventive Products
10.4 By Country

Chapter 11. Competitive Landscape
11.1 Market Share Analysis Of Key Players
11.2 Product Benchmarking Of Key Players
11.3 Global Strategic Developments Of Key Players
11.3.1 Mergers And Acquisitions
11.3.2 Partnerships
11.3.3 Other Developments

Chapter 12. Company Profiles
12.1 Global Key Players
12.1.1 3M Company
12.1.1.1 Business Overview
12.1.1.2 Product And Service Offerings
12.1.1.3 Key Financial Summary
12.1.1.4 Strategic Growth Plans
12.1.2 B. Braun Melsungen Ag
12.1.2.1 Business Overview
12.1.2.2 Product And Service Offerings
12.1.2.3 Key Financial Summary
12.1.2.4 Strategic Growth Plans
12.1.3 Becton, Dickinson And Company
12.1.3.1 Business Overview
12.1.3.2 Product And Service Offerings
12.1.3.3 Key Financial Summary
12.1.3.4 Strategic Growth Plans
12.1.4 Steris Plc
12.1.4.1 Business Overview
12.1.4.2 Product And Service Offerings
12.1.4.3 Key Financial Summary
12.1.4.4 Strategic Growth Plans
12.1.5 Stryker Corporation
12.1.5.1 Business Overview
12.1.5.2 Product And Service Offerings
12.1.5.3 Key Financial Summary
12.1.5.4 Strategic Growth Plans
12.1.6 Medtronic Plc
12.1.6.1 Business Overview
12.1.6.2 Product And Service Offerings
12.1.6.3 Key Financial Summary
12.1.6.4 Strategic Growth Plans
12.1.7 Prescient Surgical Inc.
12.1.7.1 Business Overview
12.1.7.2 Product And Service Offerings
12.1.8 Covalon Technologies Ltd.
12.1.8.1 Business Overview
12.1.8.2 Product And Service Offerings
12.1.8.3 Key Financial Summary
12.1.9 Surgical Site Infection Prevention Llc
12.1.9.1 Business Overview
12.1.9.2 Product And Service Offerings
12.1.10 Mölnlycke Health Care Ab
12.1.10.1 Business Overview
12.1.10.2 Product And Service Offerings
12.1.10.3 Key Financial Summary
12.1.11 Hartmann Group
12.1.11.1 Business Overview
12.1.11.2 Product And Service Offerings
12.1.11.3 Key Financial Summary
12.2 Regional Players
12.2.1 Nex Medical Antiseptics Srl
12.2.2 Medica Europe Bv
12.2.3 Exoxemis Inc.
12.2.4 Medi-Lin
12.2.5 Winner Medical Co. Ltd.
12.2.6 Shalex Overseas Pvt. Ltd.

Chapter 13. Appendix
13.1 Abbreviations
13.2 Sources And References
13.3 Related Report
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3M Company
  • STERIS plc
  • Stryker Corporation
  • Medtronic plc
  • Prescient Surgical Inc.
  • Covalon Technologies Ltd.
  • Surgical Site Infection Prevention LLC
  • HARTMANN GROUP
  • Mölnlycke Health Care AB
  • Becton
  • Dickinson Company.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll